ESR1 and breast carcinoma: Second, we demonstrated that low LLGL2/SLC7A5 mRNA co-expression (LLGL2low/SLC7A5low) was also an independent favorable prognostic factor both in all breast cancer patients and in Erα-positive breast cancer patients.